Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04748809 · ClinicalTrials.gov registry record · NA

Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

A NA study of Rheumatoid Arthritis, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT04748809 is a NA study of Rheumatoid Arthritis that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 124 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04748809, a NA study of Rheumatoid Arthritis, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

In a previous exploratory study, the investigators observed an effect on disease activity outcomes of anti-inflammatory diet. The investigators also observed change in microbiome and circulating metabolites. The current study will determine whether or not the addition of anti-inflammatory diet improves the clinical outcomes in participants with rheumatoid arthritis, and the role of microbiome and circulating metabolites.

Conditions Studied

Interventions

  • OTHER Diet 1
  • OTHER Diet 2

Study Locations (1)

California

  • UCSD - La Jolla

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2020-11-01
Est. Completion 2026-03-01
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT04748809

The ClinicalTrials.gov registry entry for NCT04748809 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Diet 1 is the first listed.

NCT04748809 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04748809 about?

NCT04748809 is a clinical study titled "Effect of Anti-inflammatory Diet in Rheumatoid Arthritis". In a previous exploratory study, the investigators observed an effect on disease activity outcomes of anti-inflammatory diet. The investigators also observed change in microbiome and circulating metabolites. The current study will determine whether or not the addition of anti-inflammatory diet impro...

What is the current status of trial NCT04748809?

This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2020-11-01. Estimated completion is 2026-03-01.

What conditions does trial NCT04748809 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT04748809?

The interventions under investigation include: Diet 1 (OTHER), Diet 2 (OTHER).

Who is sponsoring clinical trial NCT04748809?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04748809 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.